More Than Words
WORD FERRET IS 100% LLM-FREE
Now Pharma
Rare Disease CRO
Home About us Services News Contact
Personal message for John Smith of Sponsor Pharma (Role Play)
Audio-only track
Hi, John.
I've worked in the rare disease space for years and have been following Sponsor Pharma's successes, most notably the recent OP-101 Phase II study for porphyria.
Now Pharma is a specialist CRO in rare disease clinical trials, including porphyria studies. With the announcement of the planned OP-101 Phase III study, now may be a good time to connect. Our porphyria trial experience has shown that in addition to a well-designed protocol, dynamic supply management, a patient-centric approach, and strong analysis tools and methodologies, the CRO's level of relevant experience in this therapeutic area is critical.
Would you be open to having an introduction call? I could share insights that may be helpful for you. My calendar is here if you'd like to compare schedules.
Kind regards,
Ray
Ray Collia
Director of Relationship Development
Now Phrama Rare Disease CRO
Direct Dial +44 1234 123456
Email contact@nowpharma.com
Resources for John Smith
Please note that this is a sample page. The website links below are not live.
Porphyria Clinical Trial Case Study
Download
Overcoming Challenges in Rare Disease Studies
Download
Increasing Patient Retention
Download
About Now Pharma
We are a global CRO who have specialised in rare diseases for over 20 years.
-
Biostatistics
-
Clinical Operations
-
Data Management
-
DCT
-
Finance and Travel Management
-
HEOR
-
Labs
We understand the specific patient needs and challenges that arise from many rare and orphan diseases, and the urgency faced by clinicians to gather the most meaningful and accurate data possible from point of every patient interaction and sample.
-
Logistics
-
Manufacturing
-
Patients
-
Quality
-
Regulatory Affairs
-
Sites
We have experience in over 200+ rare indications that include:
Age-related Macular Degeneration
Alpha-1 antitrypsin deficiency
Alport Syndrome
Amyotrophic Lateral Sclerosis
Autism Spectrum Disorders
Cystic fibrosis
Cystinosis
Dravet Syndrome
Duchenne Muscular Dystrophy
Duchenne’s muscular dystrophy
Epidermolysis bullosa
Fabry Disease
Fragile X Syndrome
Friedrich’s ataxia
Gaucher Disease
HAE
Hereditary Inclusion Body MyopathyMultiple Sclerosis
Neuro-autoimmune
Neuro-Ophthalmology
Neuromuscular Disorder
Niemann-Pick Type C1 DiseasePAH
PNH
Pompe Disease
Porphyria
Prader Willi Syndrome
Rare Genetic Syndromes
Rare oncology indications, such as mesothelioma and multiple lymphomas
Retinal vein occlusion
Rett Syndrome
Stargardt’s Disease
Systemic sclerosis
Urea cycle disorders
Uveitis
X-Linked Myotubular Myopathy
Privacy policy
Now Pharma
Rare Disease CRO